Bruker Corp
NASDAQ:BRKR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
48.25
94.27
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BRKR stock under the Base Case scenario is 70.32 USD. Compared to the current market price of 57.07 USD, Bruker Corp is Undervalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Bruker Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BRKR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Bruker Corp
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Bruker Corporation stands as a pivotal player in the life sciences and analytical instrument markets, renowned for its innovative technologies that empower researchers and laboratories worldwide. Founded in 1960, Bruker has consistently focused on developing advanced scientific instruments that enhance the understanding of biological processes and materials. Through its diverse portfolio, which includes high-performance mass spectrometry, nuclear magnetic resonance (NMR), and microscopy systems, Bruker addresses critical challenges in fields such as drug discovery, environmental analysis, and clinical diagnostics. With a commitment to innovation, the company is well-positioned to benefit fro...
Bruker Corporation stands as a pivotal player in the life sciences and analytical instrument markets, renowned for its innovative technologies that empower researchers and laboratories worldwide. Founded in 1960, Bruker has consistently focused on developing advanced scientific instruments that enhance the understanding of biological processes and materials. Through its diverse portfolio, which includes high-performance mass spectrometry, nuclear magnetic resonance (NMR), and microscopy systems, Bruker addresses critical challenges in fields such as drug discovery, environmental analysis, and clinical diagnostics. With a commitment to innovation, the company is well-positioned to benefit from ongoing trends in healthcare and life sciences, promising an exciting growth trajectory for potential investors.
As the global scientific community increasingly turns to precise analytics and advanced diagnostics, Bruker’s offerings align perfectly with the burgeoning demand for cutting-edge research tools. The company has cultivated strong relationships with academic institutions, government agencies, and pharmaceutical companies, ensuring a robust customer base. Furthermore, with a focus on sustainability and reducing environmental impact, Bruker is tapping into new market segments that prioritize eco-friendly solutions. With a solid financial foundation, a history of strategic acquisitions, and ongoing investments in research and development, Bruker Corporation represents a compelling opportunity for investors looking to gain exposure to the dynamic fields of life sciences and analytical technology.
Bruker Corporation is a global leader in scientific instruments and analytical solutions. The company segments its business primarily into the following core areas:
-
Life Sciences: This segment focuses on providing innovative solutions for biological and biomedical research. It includes a range of products such as mass spectrometry systems, NMR (nuclear magnetic resonance) systems, and microscopy tools. Key applications include drug discovery, proteomics, genomics, and molecular biology.
-
Applied Markets: Bruker serves a variety of industries in this segment, including pharmaceuticals, food and agriculture, and environmental monitoring. The products in this segment often involve analytical instruments used for quality control, food safety testing, and materials characterization.
-
Materials and Nano Analysis: This segment provides solutions for characterizing materials at the nanoscale. It includes electron microscopy and surface analysis instruments. The main applications are in materials science, nanotechnology, and semiconductor manufacturing.
-
Industrial Technology: Bruker offers products and services tailored to industrial applications such as manufacturing process control, quality assurance, and inspection. The focus is on providing analytical instruments that help industries improve efficiency and compliance.
-
Pharmaceuticals and Biotechnology: This area specifically targets the pharmaceutical and biotech sectors, offering advanced analytical tools for drug development and production. Products such as mass spectrometers and imaging systems aid in research and quality assessment.
These segments reflect Bruker's commitment to delivering high-performance analytical solutions that meet the diverse needs of its customers across various scientific disciplines and industries. The company's focus on innovation, quality, and customer service helps maintain its strong market position.
Bruker Corporation, a leader in scientific instruments and analytical solutions, holds several unique competitive advantages in its industry. Here are some of the key factors that distinguish Bruker from its rivals:
-
Diversified Product Portfolio: Bruker offers a broad range of high-performance analytical instruments and systems for various applications, including life sciences, pharmaceuticals, environmental analysis, and materials science. This diversification allows Bruker to cater to multiple market segments, reducing dependency on any single sector.
-
Advanced Technology and Innovation: Bruker invests heavily in research and development, enabling it to stay at the forefront of technological advancements. Its commitment to innovation results in cutting-edge products that often outperform competitors in terms of precision, reliability, and ease of use.
-
Strong Intellectual Property: Bruker holds numerous patents and proprietary technologies, providing a barrier to entry for competitors and allowing for differentiation in product offerings. This intellectual property helps Bruker maintain a leadership position in various scientific and analytical fields.
-
Market Leadership in Niche Segments: Bruker is a prominent player in several niche markets, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. Its reputation for quality and reliability in these areas helps establish strong customer loyalty.
-
Robust Global Distribution Network: The company has an extensive global distribution and service network. This allows for efficient delivery and support of products, enhancing customer relationships and satisfaction.
-
Strong Customer Relationships: Bruker places a strong emphasis on customer relationships and provides tailored solutions to meet unique client needs. This customer-centric approach fosters loyalty and repeat business.
-
Expertise and Brand Reputation: With decades of experience in the industry, Bruker has built a strong brand reputation associated with quality and innovation. This trust can influence purchasing decisions in a market where reliability is critical.
-
Partnerships and Collaboration: Bruker engages in strategic partnerships with research institutions and other organizations, which can enhance its product development capabilities and market reach.
-
Sustainability Initiatives: As the industry shifts towards more sustainable practices, Bruker is positioned well with its commitment to environmentally friendly practices and solutions, appealing to a growing segment of environmentally conscious customers.
-
Resilience and Adaptability: Bruker has demonstrated the ability to adapt to changing market conditions and customer needs, allowing it to navigate economic uncertainties better than some competitors.
These competitive advantages position Bruker Corporation favorably against its rivals in the scientific instrumentation market, enabling it to maintain its leadership and drive future growth.
Bruker Corporation, a leading manufacturer of scientific instruments and analytical solutions, faces several risks and challenges in the near future. Here are some key areas to consider:
-
Market Competition: The scientific instruments market is highly competitive, with both established players and new entrants. Bruker faces pricing pressure and the need for continual innovation to maintain its market position.
-
Technological Advancements: Rapid technological changes require Bruker to invest in research and development continuously. Failing to keep pace with advancements could lead to obsolescence.
-
Economic Conditions: Economic downturns or fluctuations can impact funding for research and development in both academia and industry, which may reduce demand for Bruker’s products.
-
Supply Chain Disruptions: Global supply chain issues, including sourcing materials and components, can lead to production delays and increased costs. This is particularly critical in the current geopolitical climate.
-
Regulatory Environment: The company operates in a heavily regulated industry. Changes in regulations, particularly in healthcare and environmental standards, can impose additional compliance costs or restrict product offerings.
-
Intellectual Property Risks: Protection of intellectual property is crucial in the technology sector. Bruker must be vigilant against patent infringement and ensure its innovations are protected.
-
Customer Concentration: A significant portion of revenue may come from a limited number of customers or specific sectors. Dependence on these customers can lead to volatility in revenues.
-
Cybersecurity Threats: As a technology-driven company, Bruker must address potential cybersecurity threats to protect sensitive data and intellectual property.
-
Geopolitical Risks: Trade tensions and geopolitical instability can impact Bruker’s operations, particularly if they rely on international markets for sales or supply chain.
-
Talent Acquisition and Retention: The ability to attract and retain skilled professionals in a competitive labor market is critical for sustaining innovation and operational efficiency.
Navigating these risks while leveraging strengths such as strong brand reputation, diverse product offerings, and a solid customer base will be crucial for Bruker’s sustained growth and competitive advantage.
Revenue & Expenses Breakdown
Bruker Corp
Balance Sheet Decomposition
Bruker Corp
Current Assets | 2.2B |
Cash & Short-Term Investments | 148.1m |
Receivables | 712.9m |
Other Current Assets | 1.3B |
Non-Current Assets | 3.9B |
PP&E | 841.4m |
Intangibles | 2.5B |
Other Non-Current Assets | 579m |
Current Liabilities | 1.3B |
Accounts Payable | 227.5m |
Other Current Liabilities | 1.1B |
Non-Current Liabilities | 3B |
Long-Term Debt | 2.3B |
Other Non-Current Liabilities | 719.3m |
Earnings Waterfall
Bruker Corp
Revenue
|
3.2B
USD
|
Cost of Revenue
|
-1.6B
USD
|
Gross Profit
|
1.6B
USD
|
Operating Expenses
|
-1.2B
USD
|
Operating Income
|
370.3m
USD
|
Other Expenses
|
-65.4m
USD
|
Net Income
|
304.9m
USD
|
Free Cash Flow Analysis
Bruker Corp
USD | |
Free Cash Flow | USD |
In Q3 2024, Bruker reported a 16.4% increase in revenue to $864 million, with 3.1% organic growth. Challenges remain, particularly in biopharma and China, prompting a revenue guidance adjustment to $3.34-$3.37 billion and 3-4% organic growth. Non-GAAP EPS fell to $0.60, down 18.9%, while operating margins decreased to 14.9%. Looking ahead, Bruker expects low single-digit organic growth for Q4 but aims for significant margin improvement and above-market growth in 2025 amid stimulus-driven demand recovery in China and ongoing strong performance in diagnostics and semiconductor tools.
What is Earnings Call?
BRKR Profitability Score
Profitability Due Diligence
Bruker Corp's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Bruker Corp's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
BRKR Solvency Score
Solvency Due Diligence
Bruker Corp's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Bruker Corp's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BRKR Price Targets Summary
Bruker Corp
According to Wall Street analysts, the average 1-year price target for BRKR is 74.47 USD with a low forecast of 54.54 USD and a high forecast of 89.25 USD.
Dividends
Current shareholder yield for BRKR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
BRKR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 7,765 full-time employees. The company went IPO on 2000-08-04. The firm operates through four segments: Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Group and Bruker Energy & Supercon Technologies (BEST). The Bruker BioSpin Group segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The Bruker CALID Group segment designs, manufactures, and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions. The BSI NANO Group segment designs and manufactures advanced X-ray instruments; advanced fluorescence optical microscopy instruments; analytical tools for electron microscopes and X-ray metrology; and defect-detection equipment. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.
Contact
IPO
Employees
Officers
The intrinsic value of one BRKR stock under the Base Case scenario is 70.32 USD.
Compared to the current market price of 57.07 USD, Bruker Corp is Undervalued by 19%.